Spacer

 
Policy
spacer
 

Policies & Reports



NIH March-In Response
  • March-In Determination in the Case of Fabrazyme
  • March-In Position Paper in the case of Xalatan
  • March-In Position Paper in the case of Norvir
  • Public Meeting- NIH- May 25, 2004 Norvir (ritonavir)
  • March-In Determination in the Case of CellPro


  • Congressional Interest in NIH Technology Transfer
  • NIH Response to the Conference Report Request for a Plan to Ensure Taxpayers' Interests are Protected (July 2001)
  • General Accountability Office (GAO) Report RCED-99-242- Technology Transfer - Reporting Requirements for Federally Sponsored Inventions (August 1999)
  • GAO Report RCED-99-173 Technology Transfer: Number and Characteristics of Inventions Licensed by Six Federal Agencies (June 1999)
  • Report to Congress on Affordability of Inventions and Products (July 2004)


  • Policies & Reports Archives...
  •  
    Spacer
    Note that this site uses cookies, Click here for more information.